Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma.

Soares AB, Demasi AP, Altemani A, de Araújo VC.

Histopathology. 2011 Feb;58(3):377-82. doi: 10.1111/j.1365-2559.2011.03758.x. Epub 2011 Feb 16.

PMID:
21323961
2.

Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation.

Demasi AP, Furuse C, Soares AB, Altemani A, Araújo VC.

Hum Pathol. 2009 Mar;40(3):390-7. doi: 10.1016/j.humpath.2008.06.030. Epub 2008 Nov 7.

PMID:
18992915
3.

Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.

de Souza AA, Altemani A, Passador-Santos F, Turssi CP, de Araujo NS, de Araújo VC, Soares AB.

Virchows Arch. 2015 Sep;467(3):295-301. doi: 10.1007/s00428-015-1804-x. Epub 2015 Jul 9.

PMID:
26155914
4.

An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.

Hoch BL, Wu M, Lewis M, Gan L, Burstein DE.

J Oral Pathol Med. 2008 Nov;37(10):634-8. doi: 10.1111/j.1600-0714.2008.00680.x. Epub 2008 Jul 29.

PMID:
18673415
5.

Aberrant protein expression and promoter methylation of p16 gene are correlated with malignant transformation of salivary pleomorphic adenoma.

Hu YH, Zhang CY, Tian Z, Wang LZ, Li J.

Arch Pathol Lab Med. 2011 Jul;135(7):882-9. doi: 10.1043/2010-0181-OARI.1.

PMID:
21732778
6.

Study of histopathological, morphological and immunohistochemical features of recurrent pleomorphic adenoma: an attempt to predict recurrence of pleomorphic adenoma.

Soares AB, Altemani A, de Araújo VC.

J Oral Pathol Med. 2011 Apr;40(4):352-8. doi: 10.1111/j.1600-0714.2010.00956.x. Epub 2010 Oct 24.

PMID:
20969626
7.

Advances in salivary gland pathology.

Cheuk W, Chan JK.

Histopathology. 2007 Jul;51(1):1-20. Epub 2007 May 31. Review.

PMID:
17539914
8.
9.

[Ezrin and inducible nitric oxide synthase in malignant proliferation of salivary gland pleomorphic adenoma].

Wang YY, Chen WL, Zhang WX, Bai ZB, Huang ZQ, Li JS.

Ai Zheng. 2009 Oct;28(10):1072-6. Chinese.

PMID:
19799816
10.

Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions.

Di Palma S.

Head Neck Pathol. 2013 Jul;7 Suppl 1:S68-76. doi: 10.1007/s12105-013-0454-z. Epub 2013 Jul 3. Review.

12.

Cell membrane expression of MIB-1 in salivary gland pleomorphic adenoma.

Tashiro T, Hirokawa M, Harada H, Yokoyama S, Sano T.

Histopathology. 2002 Dec;41(6):559-61. No abstract available.

PMID:
12460210
13.

The increased PDGF-A, PDGF-B and FGF-2 expression in recurrence of salivary gland pleomorphic adenoma.

Soares AB, Demasi AP, Tincani AJ, Martins AS, Altemani A, de Araújo VC.

J Clin Pathol. 2012 Mar;65(3):272-7. doi: 10.1136/jclinpath-2011-200405. Epub 2011 Dec 15.

PMID:
22174424
14.

Tumours of the salivary glands: a histological and clinical review.

Pogrel MA.

Br J Oral Surg. 1979 Jul;17(1):47-56.

PMID:
224900
15.
16.

CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.

Meer S, Altini M.

Histopathology. 2007 Jul;51(1):26-32.

PMID:
17593078
17.

Clear cell carcinoma arising in pleomorphic adenoma of the minor salivary gland.

Klijanienko J, Micheau C, Schwaab G, Marandas P, Friedman S.

J Laryngol Otol. 1989 Aug;103(8):789-91.

PMID:
2549142
18.

Distribution of the VLA family of integrins in normal salivary gland and in pleomorphic adenoma.

Sunardhi-Widyaputra S, Van Damme B.

Pathol Res Pract. 1994 Jun;190(6):600-8.

PMID:
7984519
19.
20.

Caveolin-1 overexpression in benign and malignant salivary gland tumors.

Jaafari-Ashkavandi Z, Ashraf MJ, Nazhvani AD, Azizi Z.

Tumour Biol. 2016 Feb;37(2):1863-9. doi: 10.1007/s13277-015-3968-z. Epub 2015 Sep 1.

PMID:
26323261

Supplemental Content

Support Center